“Unleashing the Power of Proactive Investing: Breaking Down the Latest News from Top Companies”
Sona Nanotech Inc Publishes Preclinical Cancer Therapy Study in Frontiers in Immunology Introduction Sona Nanotech Inc (CSE:SONA, OTCQB:SNANF) made waves earlier this week with the announcement of its groundbreaking preclinical cancer therapy study published in Frontiers in Immunology. The study highlighted the company’s innovative Targeted Hyperthermia Therapy (THT) using patented gold nanorod technology to effectively…